Novel 1,8-Naphthyridone Derivatives as Adenosine Receptors (ARs) Antagonists: Design, Synthesis and Biological Evaluation
Applied Sciences · 14.11.2026 · 16 (22) · 11301
DOI: 10.3390/app162211301 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Sciences, online erschienen am 14.11.2026. Verfasst von Francesca Catarzi und 9 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BBSRC, David James Trust Fund, Royal Society Industry Fellow.
Abstract (Originalsprache)
In this paper, we report the progress of our research on adenosine A1/A3 receptor antagonists, aimed at identifying new small molecules for therapeutic applications. Starting from two recently published reference compounds, we have synthesized new products with 1,8-naphthyridone scaffold performing targeted chemical modifications at positions 1 or 3. These elaborations led to compounds that maintained affinity for the inhibitory adenosine receptors A1 and A3 but lower selectivity compared to the reference compounds. The best balance between affinity and selectivity was found for 4f (pKi A1R < 4; pKi A3R = 6.25 ± 0.10) and 4i (pKi A1R = 4.91 ± 0.02; pKi A3R = 6.51 ± 0.15), whose antagonist profile and selectivity against A2AR were determined through NanoBRET binding assay. Overall, these results can be useful in guiding the optimization process of small-molecule heterocyclic A1R/A3R receptor antagonists, facilitating their future development into effective therapeutic agents.
Förderung
- BBSRC
- David James Trust Fund
- Royal Society Industry Fellow
Zitieren
APA
Catarzi, F., Chew, E. X. Y., Crocetti, L., Pearce, A., Zaeim, A., Dexter, A., Guerrini, G., Cilibrizzi, A., Ladds, G., & Giovannoni, M. P. (2026). Novel 1,8-Naphthyridone Derivatives as Adenosine Receptors (ARs) Antagonists: Design, Synthesis and Biological Evaluation. Applied Sciences, 16(22), 11301. https://doi.org/10.3390/app162211301
Vancouver
Catarzi F, Chew EXY, Crocetti L, Pearce A, Zaeim A, Dexter A, et al. Novel 1,8-Naphthyridone Derivatives as Adenosine Receptors (ARs) Antagonists: Design, Synthesis and Biological Evaluation. Applied Sciences. 2026;16(22):11301. doi:10.3390/app162211301
BibTeX
@article{Catarzi2026,
author = {Catarzi, Francesca and Chew, Elizabeth Xin Yin and Crocetti, Letizia and Pearce, Abigail and Zaeim, Ali and Dexter, Aaron and Guerrini, Gabriella and Cilibrizzi, Agostino and Ladds, Graham and Giovannoni, Maria Paola},
title = {Novel 1,8-Naphthyridone Derivatives as Adenosine Receptors (ARs) Antagonists: Design, Synthesis and Biological Evaluation},
journal = {Applied Sciences},
year = {2026},
volume = {16},
number = {22},
pages = {11301},
doi = {10.3390/app162211301}
}
EUVIMED